Accelerating Medical Innovations

from Concept to Commercial Impact

Partnering with researchers, clinicians, and life science innovators to transform breakthrough technologies into clinical and commercial success.

Turning Innovation Into Impact

Strategy, validation, and partnerships working together to bring medical technologies to market successfully.
newImg1

Strategy & Commercialization

Driving market and product pathways for emerging medical technologies
newImg2

Clinical Insight & Validation

Ensuring clinical relevance and clinical efficacy
newImg3

Partnership & Growth

Building strategic alliances to accelerate adoption
babystrong-image-feeding

BabyStrong

Breakthrough in Infant Feeding Therapy

BabyStrong is an innovative, non-invasive therapy that combines transcutaneous auricular vagus nerve stimulation (taVNS) with bottle feeding to improve feeding outcomes for preterm and term infants who struggle with oral feeding.

Key Features:

Innovative, non-invasive therapy for neonatal feeding difficulty

Enhances neural motor learning to improve feeding outcomes

Potential benefits:

Reduced need for invasive feeding methods

Lower hospital costs and experience NICU capacity

Application settings: NICUs, pediatric rehab centers, and home healthcare environments.

newImg8

Accelerate Your Innovation Journey

Bringing a medical breakthrough to market takes more than great science—it requires the right strategy, validation, and partnerships. FRD Accel works alongside innovators to turn complex ideas into real-world healthcare solutions that improve lives.
Whether you’re in early research or preparing for commercialization, our team is ready to help you move forward with clarity and confidence.

Our Mission

Empowering medical technology innovators to transform discoveries into patient-ready solutions.

Our Vision

Advancing healthcare through impactful innovation and strategic collaboration.
Protected By
WebPro360 ShieldPRO